Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases

Samuel, Varman T., Shulman, Gerald I.·2018·Cell Metabolism

DOI 10.1016/j.cmet.2017.08.002

Cited by (744)

Items 201–300 of 744

The Potential Use of Metabolic Cofactors in Treatment of NAFLD
Adil Mardinoğlu, Dilek Ural, Müjdat Zeybel, Hatice Hilal Yuksel, Mathias Uhlén, Jan Borén · 2019 · Nutrients
Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats
Yuanjun Deng, Maoxing Pan, Huan Nie, Chuiyang Zheng, Kairui Tang, Yupei Zhang, Qinhe Yang · 2019 · Molecules
HDO production from [2H7]glucose Quantitatively Identifies Warburg Metabolism
Rohit Mahar, Patrick L. Donabedian, Matthew E. Merritt · 2020 · Scientific Reports
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Gabriele Mocciaro, Amalia Gastaldelli · 2022 · Handbook of experimental pharmacology
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease
Ilaria Barchetta, Carla Lubrano, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Arianna Dellanno, A Biasio, Frida Leonetti, Gianfranço Silecchia, Andrea Lenzi et al. · 2022 · Hepatology International
Insulin‐like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Jiaqi Pan, Cen Li, Tianyu Zhou, Mengli Yu, Xueyang Chen, Wenxi Jiang, Youming Li, Chaohui Yu, Zhe Shen · 2021 · Journal of Gastroenterology and Hepatology
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Alessandro Bavaresco, Pierluigi Mazzeo, Martina Lazzara, Mattia Barbot · 2024 · Biochemical Pharmacology
Galectin-12 in Cellular Differentiation, Apoptosis and Polarization
Lei Wan, Ri‐Yao Yang, Fu‐Tong Liu · 2018 · International Journal of Molecular Sciences
A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease
Nadia Panera, Barbara Barbaro, Claudia Della Corte, Antonella Mosca, Valério Nobili, Anna Alisi · 2018 · Nutrition Research
The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease
Christian von Loeffelholz, Johannes Roth, Sina Maren Coldewey, Andreas L. Birkenfeld · 2021 · Biomedicines
The Proton-Coupled Monocarboxylate Transporter Hermes Is Necessary for Autophagy during Cell Death
Velentzas, Panagiotis D., Zhang, Lejie, Das, Gautam, Chang, Tsun-Kai, Nelson, Charles, Kobertz, William R., Baehrecke, Eric H. · 2018 · Developmental Cell
Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.‐H. Wang, György Baffy, Piero Portincasa · 2021 · International Journal of Molecular Sciences
Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS
Xing Yan, Linnan Li, Pei Liu, Jie Xu, Zhengtao Wang, Lili Ding, Li Yang · 2022 · Journal of Pharmaceutical and Biomedical Analysis
The kinase PKD3 provides negative feedback on cholesterol and triglyceride synthesis by suppressing insulin signaling
Alexander E. Mayer, Mona C. Löffler, Angel Loza‐Valdes, Werner Schmitz, Rabih El‐Merahbi, Jonathan Trujillo Viera, Manuela Erk, Thianzhou Zhang, Ursula Braun, Mathias F Heikenwälder et al. · 2019 · Science Signaling
PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
Rajashree Rana, Andrew M. Shearer, Elizabeth K. Fletcher, Nga Nguyen, Srijoy Guha, Daniel H. Cox, Manal F. Abdelmalek, Ying Wang, James Baleja, Lidija Covic et al. · 2019 · Molecular Metabolism
Punicalagin Prevents Hepatic Steatosis through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet‐Fed Mice
Huanhuan Liu, Qiuyao Zhan, Xin Miao, Xiaodong Xia, Gaoji Yang, Xiaoli Peng, Chunhong Yan · 2020 · Molecular Nutrition & Food Research
Advances in Exercise, Physical Activity, and Diabetes Mellitus
Trevor Teich, Dessi P. Zaharieva, Michael Charles Riddell · 2019 · Diabetes Technology & Therapeutics
GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota
Jing Xiao, Huanyu Xiang, Hongyan Xiang, Zilin Sun, Jing Xu, Hong Ren, Peng Hu, Mingli Peng · 2023 · European Journal of Pharmacology
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
Hao Sun, Jongsook Kim Kemper · 2023 · Experimental & Molecular Medicine
Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease
X. Wang, Xingfei Chen, Hanyue Zhang, Juan Pang, Jing Lin, Xianyin Xu, Lijuan Yang, Junxuan Ma, Wenhua Ling, Yu‐Ming Chen · 2019 · Diabetes & Metabolism
KLF15‐activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF‐κB‐FGF21 or SREBP1c‐FGF21 pathway
Lulu Zhou, Li Zhao, Ao Chen, Na Liu, Ning Chen, Xiaojun Chen, Lin Zhu, Benzeng Xia, Yuqing Gong, Xiaodong Chen · 2019 · The FASEB Journal
High-Fat Diets with Differential Fatty Acids Induce Obesity and Perturb Gut Microbiota in Honey Bee
Xiaofei Wang, Zhaopeng Zhong, Xiangyin Chen, Ziyun Hong, Weimin Lin, Xiaohuan Mu, Xiaosong Hu, Hao Zheng · 2021 · International Journal of Molecular Sciences
Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
Cécilia Patitucci, Juan Diego Hernández‐Camacho, Elodie Vimont, Sonny Yde, Thomas Cokelaer, Thibault Chaze, Quentin Giai Gianetto, Mariette Matondo, Anastasia D. Gazi, Ivan Nemazanyy et al. · 2023 · Nature Communications
Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion
Mónica B. Jiménez‐Castro, María Eugenia Cornide‐Petronio, Jordi Gracia‐Sancho, Araní Casillas-Ramírez, Carmen Peralta · 2019 · International Journal of Molecular Sciences
Protective effects of glycycoumarin on liver diseases
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu · 2019 · Phytotherapy Research
C‐peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: A real‐world study
Yajing Huang, Yahao Wang, Chuanfeng Liu, Yue Zhou, Xiang Wang, Bingfei Cheng, Kui Che, Yangang Wang · 2021 · Diabetes/Metabolism Research and Reviews
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity
Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranço Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo · 2023 · International Journal of Molecular Sciences
The Fruit Fly, Drosophila melanogaster: Modeling of Human Diseases (Part II)
Mariateresa Allocca, Sheri Zola, Paola Bellosta · 2018 · InTech eBooks
The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes
Erika Bezerra Parente, Emma H. Dahlström, Valma Harjutsalo, Jussi Inkeri, Stefan Mutter, Carol M. Forsblom, Niina Sandholm, Daniel Gordin, Per‐Henrik Groop · 2021 · Diabetes Care
ChREBP‐driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High‐Fat Diet‐Fed Rat Model
Ana Magdalena Velázquez, Roger Bentanachs, Aleix Sala‐Vila, Iolanda Lázaro, José Rodríguez-Morató, Rosa M. Sánchez, Marta Alegret, Núria Roglans, Juan Carlos Laguna · 2022 · Molecular Nutrition & Food Research
Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals
Kitt Falk Petersen, Sylvie Dufour, Fangyong Li, Douglas L. Rothman, Gerald I. Shulman · 2022 · JCI Insight
Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation
Yuko Hino, Katsuya Nagaoka, Shinya Oki, Kan Etoh, Shinjiro Hino, Mitsuyoshi Nakao · 2022 · Nucleic Acids Research
Macrophages as Key Players during Adipose Tissue–Liver Crosstalk in Nonalcoholic Fatty Liver Disease
Hannelie Korf, Markus Boesch, Lore Meelberghs, Van der Merwe · 2019 · Seminars in Liver Disease
Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet‐induced ER stress
Meichan Yang, Deqiang Zhang, Zifeng Zhao, Julian Sit, Mischael Saint-Sume, Omar Shabandri, Kezhong Zhang, Lei Yin, Xin Tong · 2020 · The FASEB Journal
Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus
Enxiang Zhang, Yang Zhao, Hongbo Hu · 2021 · Hepatology Communications
Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice
Fei Xiong, Zhongdaixi Zheng, Lingyu Xiao, Chuhong Su, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Huiyu Luo, Longying Zha · 2021 · Molecular Nutrition & Food Research
Ficus hirta Vahl. Ameliorates Nonalcoholic Fatty Liver Disease through Regulating Lipid Metabolism and Gut Microbiota
Ting Quan, Fang-Yu Zhou, Hui-Yuan Chen, Lina Jian, Yuxuan Yang, Fan Xia, Shijian Xiang, Benjie Zhou, Shasha Li · 2022 · Oxidative Medicine and Cellular Longevity
Mystery of bisphenol F-induced nonalcoholic fatty liver disease-like changes: Roles of Drp1-mediated abnormal mitochondrial fission in lipid droplet deposition
Linwei Zhang, Xuexue Xie, Jingxian Tao, Sizhe Wang, Miaoyang Hu, Xi Wang, Zheng Yu, Liuting Xu, Yuxin Lin, Weilan Wu et al. · 2023 · The Science of The Total Environment
Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review
Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, Zahra Khorasanchi · 2024 · Food Science & Nutrition
Sex- and age-associated factors drive the pathophysiology of MASLD
Ajay K. Yadav, Justin J. MacNeill, Aleksei Krylov, Nadia Ashrafi, Romana Ashrafi Mimi, Romil Saxena, Sheng Liu, Stewart Francis Graham, Jun Wan, Núria Morral · 2024 · Hepatology Communications
Nonalcoholic Fatty Liver Disease and the Kidney: A Review
I. Umbro, Francesco Baratta, Francesco Angelico, Maria Del Ben · 2021 · Biomedicines
Prothioconazole and prothioconazole-desthio induced different hepatotoxicities via interfering with glycolipid metabolism in mice
Sinuo Tian, Hang Yan, Zhiyuan Meng, Ming Jia, Wei Sun, Shiran Huang, Yu Wang, Zhiqiang Zhou, Jinling Diao, Wentao Zhu · 2021 · Pesticide Biochemistry and Physiology
Albumin knockout mice exhibit reduced plasma free fatty acid concentration and enhanced insulin sensitivity
Afsoun Abdollahi, Brianna N. Dowden, Kimberly K. Buhman, Alyssa S. Zembroski, Gregory C. Henderson · 2022 · Physiological Reports
Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease
Cristina López‐Vicario, David Sebastián, Mireia Casulleras, Marta Duran‐Güell, Roger Flores‐Costa, Ferrán Aguilar, Juan José Lozano, Ingrid Wei Zhang, Esther Titos, Jing Xuan Kang et al. · 2022 · Hepatology
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease
Jake Peter Mann, Anita C. E. Vreugdenhil, Aglaia Zellos, Aleksander Ahm Krag, Anastasia Konidari, Anna Alisi, Bart G.P. Koot, Benno Kohlmaier, Christian A. Hudert, Christos Tzivinikos et al. · 2023 · The Lancet. Gastroenterology & hepatology
Liver fat as risk factor of hepatic and cardiometabolic diseases
Münevver Demir, Stefan Richard Bornstein, Christos Socrates Mantzoros, Nikolaos Perakakis · 2023 · Obesity Reviews
Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer
Jian Ge Sun, Yan Chen, Tao Wang, Waseem Ali, Yonggang Ma, Yan Yuan, Jianhong Gu, Jianchun Bian, Zongping Liu, Hui Zou · 2023 · Cellular & Molecular Biology Letters
Impaired lipid and glucose homeostasis in male mice offspring after combined exposure to low-dose bisphenol A and arsenic during the second half of gestation
Dezhen Wang, Wentao Zhu, Sen Yan, Zhiyuan Meng, Jin Yan, Miaomiao Teng, Ming Jia, Ruisheng Li, Zhiqiang Zhou · 2018 · Chemosphere
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
Jendle, J., Hyötyläinen, T., Orešič, M., Nyström, T. · 2021 · Cardiovascular Diabetology
Circular RNAs in Metabolic Diseases
Tianhui Wang, Wen Qi Pan, Jun X. Hu, Zhongrong Zhang, Guoping Li, Yajun Liang · 2018 · Advances in experimental medicine and biology
In vitro effects of Triclocarban on adipogenesis in murine preadipocyte and human hepatocyte
Manyuan Dong, Peihong Yuan, Yuchen Song, Hehua Lei, Gui Chen, Xuehang Zhu, Fang Wu, Chuan Chen, Caixiang Liu, Zunji Shi et al. · 2020 · Journal of Hazardous Materials
The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism
Qing Zhao, Mengjuan Wei, Shaobo Zhang, Zhenlin Huang, Bin Lü, Lili Ji · 2020 · Phytomedicine
Blood manganese and nonalcoholic fatty liver disease: A cohort-based case-control study
Di Zhang, Shouling Wu, Yanqi Lan, Shuohua Chen, Yanhong Wang, Yuanyuan Sun, Wei Liao, Li Wang · 2021 · Chemosphere
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis‐related fibrosis: Multicenter study
Yuya Seko, Hirokazu Takahashi, Hidenori Toyoda, Hideki Hayashi, Kanji Yamaguchi, Michihiro Iwaki, Masato Yoneda, Taeang Arai, Toshihide Shima, Hideki Fujii et al. · 2022 · Hepatology Research
Acute Kidney Injury Induces Oxidative Stress and Hepatic Lipid Accumulation through AMPK Signaling Pathway
Kathy K. W. Au-Yeung, Yue Shang, Charith U. B. Wijerathne, Susara Madduma Hewage, Yaw Loong Siow, O Karmin · 2023 · Antioxidants
Cross-Talk of NADPH Oxidases and Inflammation in Obesity
Henning Morawietz, Heike Brendel, Patrick Diaba‐Nuhoho, Rusan Ali Catar, Nikolaos Perakakis, Christian Wolfrum, Stefan Richard Bornstein · 2023 · Antioxidants
Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis
Wei Wang, Yulin Kong, Xia Wang, Zhe Wang, Chunlei Tang, Jinyou Li, Qin Yang, Yong Q. Chen, Shenglong Zhu · 2023 · Cell Communication and Signaling
Omentectomy in Addition to Bariatric Surgery—a 5-Year Follow-up
Daniel Peter Andersson, Daniel Eriksson Hogling, Jesper Bäckdahl, Anders Thorell, Patrik Löfgren, Mikael Rydén, Peter Arner, Johan Hoffstedt · 2017 · Obesity Surgery
Novel Strategies to Prevent Total Parenteral Nutrition‐Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes
Eliana Lucchinetti, Phing‐How Lou, Paulina Wawrzyniak, Marcin Wawrzyniak, Michael M. Scharl, Gregory Holtzhauer, Stefanie D. Krämer, Martin Hersberger, Gerhard Rogler, Michael Zaugg · 2020 · Molecular Nutrition & Food Research
LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability
Jiaoxiang Wu, Kunyan He, Zhuang-Zhuang Zhang, Yu-Lan Qu, Xianbin Su, Yi Y. Shi, Na Wang, Lan Wang, Ze‐Guang Han · 2021 · PLoS Genetics
Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, Emilio Molina‐Molina, Harshitha Shanmugam, Gabriella Garruti, David Q.‐H. Wang, Piero Portincasa · 2021 · Methods in molecular biology
Adherence to the dietary approaches to stop hypertension diet and non‐alcoholic fatty liver disease
Yuanyuan Sun, Shuohua Chen, Xinyu Zhao, Yanhong Wang, Yanqi Lan, Xiaozhong Jiang, Xiang Gao, Shouling Wu, Li Wang · 2022 · Liver International
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis
Chuan Ding, Zeping Wang, Xinyue Dou, Qiao Yang, Yan Ning, Shi Kao, Xianan Sang, Min Hao, Kuilong Wang, Mengyun Peng et al. · 2023 · Aging and Disease
The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications
Yonatan Akivis, Hussam R Alkaissi, Samy I. McFarlane, Inna F. Bukharovich · 2024 · Current Cardiology Reviews
Exercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation
Vítor Rosetto Muñoz, Rafael Calais Gaspar, Gabriel Keine Kuga, Susana Castelo Branco Ramos Nakandakari, Igor L. Baptista, Rania A. Mekary, Adelino Sánchez Ramos da Silva, Leandro Pereira de Moura, Eduardo Rochete Ropelle, Dennys E. Cintra et al. · 2018 · Journal of Cellular Biochemistry
Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet
Rose FJ Cairns, Alexander W. Fischer, Patricia Blanco‐Muñoz, Anna Álvarez-Guaita, Elsa Meneses‐Salas, Antonia Egert, Christa Buechler, Andrew J. Hoy, Jöerg Heeren, Carlos Enrich et al. · 2018 · PLoS ONE
The alleviation of lipid deposition in steatosis hepatocytes by capsaicin-loaded α-lactalbumin nanomicelles via promoted endocytosis and synergetic multiple signaling pathways
Congcong Zuo, Huijuan Zhang, Shuang Liang, Wendi Teng, Cheng Bao, Dan Li, Yuling Hu, Qimeng Wang, Zekun Li, Yuan Li · 2021 · Journal of Functional Foods
Roles of Estrogens in the Healthy and Diseased Oviparous Vertebrate Liver
Blandine Tramunt, Alexandra Montagner, Nguan Soon Tan, Pierre Gourdy, Hervé Rémignon, Walter Wahli · 2021 · Metabolites
Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
Inês Sousa‐Lima, Hyun Jeong Kim, John Griffith Jones, Young‐Bum Kim · 2021 · Diabetes & Metabolism Journal
Associations of NAFLD with circulating ceramides and impaired glycemia
Meghana D. Gadgil, Monika A. Sarkar, Caroline J. Sands, Matthew R. Lewis, David M. Herrington, Alka M. Kanaya · 2022 · Diabetes Research and Clinical Practice
Honey bee as a model organism to study gut microbiota and diseases
Xiaofei Wang, Xue Zhang, Zijing Zhang, Haoyu Lang, Hao Zheng · 2018 · Drug Discovery Today Disease Models
Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
Ting Li, Hua Yan, Yan Geng, Haitao Shi, Hong Li, Shenhao Wang, Yatao Wang, Jing‐Yuan Xu, Gang Zhao, Xiaolan Lu · 2019 · Lipids in Health and Disease
Protective function on liver and proteomic analysis of the improvement mechanism of Sedum sarmentosum Bunge extract on nonalcoholic fatty liver disease in Nile tilapia
Kai Yu, Kai Huang, Shisong Jiang, Xiao Ping Tang, Xiuyun Huang, Linlin Sun, Linxing Pang, Cuiqin Mo · 2020 · Aquaculture
Celastrol: An Update on Its Hepatoprotective Properties and the Linked Molecular Mechanisms
Mengzhen Li, Faren Xie, Lu Wang, Guoxue Zhu, Lian‐Wen Qi, Shujun Jiang · 2022 · Frontiers in Pharmacology
Cross-sectional metabolic subgroups and 10-year follow-up of cardiometabolic multimorbidity in the UK Biobank
Anwar Mulugeta, Elina Hyppönen, Mika Ala‐Korpela, Ville‐Petteri Mäkinen · 2022 · Scientific Reports
Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study
Xintian Cai, Jing Sheng Gao, Shasha Liu, Meng‐Ru Wang, Junli Hu, Jing Hong, Qing Zhu, Guzailinuer Tuerxun, Yujie Dang, Nanfang Li · 2022 · Disease Markers
Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis
Maria Paula Carbonetti, Fernanda Almeida‐Oliveira, David Majerowicz · 2023 · Archives of Endocrinology and Metabolism
Apple Pomace Consumption Favorably Alters Hepatic Lipid Metabolism in Young Female Sprague-Dawley Rats Fed a Western Diet
Roy Chris Skinner, Derek Cole Warren, Soofia N. Lateef, Vagner Augusto Benedito, Janet C. L. Tou · 2018 · Nutrients
Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies
Hisanori Goto, Toshinari Takamura · 2025 · Journal of Obesity & Metabolic Syndrome
Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice
Abudukadier Abulizi, Daniel F. Vatner, Zhang Ye, Yongliang Wang, João Paulo Camporez, Dongyan Zhang, Mario Kahn, Kun Lyu, Alaa Sirwi, Gary W. Cline et al. · 2020 · Journal of Lipid Research
Albumin Deficiency Reduces Hepatic Steatosis and Improves Glucose Metabolism in a Mouse Model of Diet-Induced Obesity
Afsoun Abdollahi, Sanjeev Kumar Narayanan, Alexandra Frankovich, Yen‐Chun Lai, Yi Zhang, Gregory C. Henderson · 2023 · Nutrients
Selenium Ameliorated Oxidized Fish Oil-Induced Lipotoxicity via the Inhibition of Mitochondrial Oxidative Stress, Remodeling of Usp4-Mediated Deubiquitination, and Stabilization of Pparα
Dian-Guang Zhang, Wolfram S. Kunz, Xi-Jun Lei, Ester Zito, Tao Zhao, Yi-Chuang Xu, Xiaolei Wei, Wu-Hong Lv, Zhi Luo · 2023 · Antioxidants and Redox Signaling
The Impact and Burden of Dietary Sugars on the Liver
Helaina E. Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, Jean A. Welsh, Miriam B. Vos · 2023 · Hepatology Communications
Repression of MicroRNA-124-3p Alleviates High-Fat Diet–Induced Hepatosteatosis by Targeting Pref-1
Guan Wang, Haibo Zou, Chunyou Lai, Xiaolun Huang, Yutong Yao, Guangming Xiang · 2020 · Frontiers in Endocrinology
Non-genetic Heterogeneity of Macrophages in Diseases—A Medical Perspective
Grégoire Gessain, Camille Blériot, Florent Ginhoux · 2020 · Frontiers in Cell and Developmental Biology
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH
Gregory R. Steinberg, Jaya Gautam, James Lally, Russta Fayyazi, E. Grasset, Dipankar Bhattacharya, Gio Fidelito, Elham Ahmadi, Logan K. Townsend, Battsetseg Batchuluun et al. · 2026 · Cell Metabolism
LIFR-α-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease
Tong Guo, Arun K. Das Gupta, Jinhai Yu, Jorge Z. Granados, Aakash Y. Gandhi, Bret M. Evers, Puneeth Iyengar, Rodney Elwood Infante · 2021 · iScience
A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease
Xiaozhi Hu, Jiajun Fan, Qianqian Ma, Lei Han, Zhonglian Cao, Caili Xu, Jingyun Luan, Guangjun Jing, Yanyang Nan, Tao Wu et al. · 2022 · Journal of Nanobiotechnology
Bavachin protects against diet-induced hepatic steatosis and obesity in mice
Xiang Wei, Lin Li, Qian-qian Yuan, Xiuyun Wang, Qing Zhang, Xiaomin Zhang, Ke-chao Tang, Manyu Guo, Tingyu Dong, Wei Han et al. · 2023 · Acta Pharmacologica Sinica
Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora
Xiaolei Miao, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen · 2023 · Lipids in Health and Disease
GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
Yaqiong Li, Yi Lin, Xueya Han, Weihong Li, Wenmao Yan, Yuejiao Ma, Xin Lü, Xiaowu Huang, Rixing Bai, Haiyan Zhang · 2021 · iScience
Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model
Usman Sabir, Hafiz Muhammad Irfan, Alamgeer, Aman Ullah, Yusuf S. Althobaiti, Fahad S. Alshehri, Zahid Rasul Niazi · 2022 · Biomedicine & Pharmacotherapy
Therapeutic potential of sulforaphane in liver diseases: a review
Yan Liang, Yachun Yan · 2023 · Frontiers in Pharmacology
Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities
Ricardo Amorim, Pedro Soares, Daniel Chavarria, Sofia Benfeito, Fernando Cagide, José Teixeira, Paulo Jorge Oliveira, Fernanda Borges · 2024 · European Journal of Medicinal Chemistry
Dual extraction of mRNA and lipids from a single biological sample
Normand Podechard, Simon Ducheix, Arnaud Polizzi, Frédéric Lasserre, Alexandra Montagner, Vincent Legagneux, Edwin Fouché, Fabrice Saez, Jean‐Marc A. Lobaccaro, Laïla Lakhal et al. · 2018 · Scientific Reports
Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments
Jiao Wang, Honghong Liu, Guijiao Xie, Wei Cai, Jixiong Xu · 2019 · Molecular Medicine Reports
The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
Cecilia Östlund, Antonio Hernández‐Ono, Ji‐Yeon Shin · 2020 · Biology
INPP4B protects from metabolic syndrome and associated disorders
Manqi Zhang, Yasemin Ceyhan, Elena M. Kaftanovskaya, Judy L. Vasquez, Jean Vacher, Filip Krag Knop, Lubov Nathanson, Alexander I. Agoulnik, Michael Ittmann, Irina U. Agoulnik · 2021 · Communications Biology
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night
Thomas Marjot, Kieran Smith, Felix Westcott, Dr. Sarah White, Elspeth M. Johnson, Nikola Srnic, Amy Barrett, Ellis Hall, Kate Gralton, Kaitlyn M.J.H. Dennis et al. · 2026 · Cell Metabolism
Effects of 23-epi-26-deoxyactein on adipogenesis in 3T3-L1 preadipocytes and diet-induced obesity in C57BL/6 mice
Jingjing Yuan, Qiang‐Qiang Shi, Juan Chen, Jing Lü, Lu Wang, Ming‐Hua Qiu, Jian Liu · 2020 · Phytomedicine